|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date06 Mar 2018 |
100 Clinical Results associated with Meroven Ltd.
0 Patents (Medical) associated with Meroven Ltd.
100 Deals associated with Meroven Ltd.
100 Translational Medicine associated with Meroven Ltd.